Clinical Trial Update: A Clinical Trial Assessing the Safety and Efficacy of Biodegradable Magnesium Embolic Microspheres for Primary Hepatocellular Carcinoma [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the safety and efficacy of biodegradable magnesium embolic microspheres for non-resectable hepatocellular carcinoma; the study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Biodegradable Magnesium Embolic Microspheres

Snippet

Sponsor: InnoBM Pharmaceuticals Co., Ltd. | Conditions: Hepatocellular Carcinoma Non-Resectable | Phase 3 | Status: NOT_YET_RECRUITING